Analysis: SAIL, Jubilant Life Sciences and SJVN Limited

Modified: 04-May-21

This article provides a fundamental analysis of Steel Authority of India Ltd (SAIL), Jubilant Life Sciences Ltd and Satluj Jal Vidyut Nigam (SJVN) Ltd.

In order to benefit the maximum from this article, an investor should focus more on the process of analysis instead of looking for good or bad aspects of the company. She should learn the interpretation of different types of data and transactions and pay attention to the parts of annual reports etc used to get the information. This will help her in improving her stock analysis skills.

 

Analysis of Steel Authority of India Ltd

Q: Hi, Can you please provide your views on SAIL?

 

Dr Vijay Malik’s Response

Thanks for writing to me.

 

Financial Analysis of SAIL:

Steel Authority Of India Ltd SAIL Financials

Steel Authority of India Ltd (SAIL) is a company that has destroyed shareholder’s wealth over the years. In last decade (2005-2014), it has retained earnings worth of INR 41,698 cr. (416.98 billion) whereas its market cap has increased by only INR 8,234 cr. (82.34 billion). Shareholder’s wealth of about INR 33,000 cr. (330.00 billion) has been lost over the last decade.  It fails miserably on the test of management highlighted by Warren Buffett that the management should at least produce $1 in market value for $1 of earnings retained. If any company is not able to do this, then it should consider distributing its earnings to shareholders, in form of dividends, rather than keeping it with itself and in turn investing in a suboptimal business.

SAIL’s topline (sales) has been almost stable since last 7 years (2008-2014). Sales have grown at a meagre 1% to 4% per annum. Operating profitability (OPM) has declined from 28% in 2008 to 8% in 2014. Despite the increase in sales, from INR 40,000 cr. in 2008 to INR 47,000 cr. in 2014, the operating profit has decreased from INR 11,200 cr. in 2008 to INR 3,900 cr. 2014. Similarly, Net profitability (NPM) has declined from 19% in 2008 to 6% in 2014, indicating that during 2008-2014, despite increase in sales, net profit decreased from INR 7,500 cr. (2008) to INR 2,600cr. (2014).

When a company does not make sufficient money to fund its capital-intensive business, which itself is very low yielding, then it starts relying on debt financing to fund its cash requirements. The same thing has happened in the case of SAIL. Over last decade, total debt of SAIL has increased to almost five times, from INR 5,700 cr. in 2005 to INR 24,267 cr. in 2014. This huge debt will hurt the company in times of stress, as lenders will keep demanding their interest and principal whether the company is doing good or bad.

Therefore, looking at the past performance of Steel Authority of India Ltd (SAIL), it does not seem an attractive business to invest in. An investor can find many better opportunities in the current markets.

However, you should do your own analysis before you make any investment decision related to SAIL or any other company.

Hope it helps.

Regards,

 

Analysis of Jubilant Life Sciences Ltd

Q: Hi Mr Vijay, I am holding Jubilant Life Sciences Ltd @ Rs xx/-. It’s PE < 10 in comparison to Industry PE. From the last two/three quarters, the topline & bottom-line figures are not quite impressive. In addition, debt in the company’s book is a worrisome factor. I would request you to throw some light on this counter.

 

Dr Vijay Malik’s Response

Thanks for writing to me!

I appreciate your analysis of Jubilant Life Sciences Ltd as you have rightly pointed out the problem areas in the company.

 

Financial Analysis of Jubilant Life Sciences Ltd:

Jubilant Life Sciences Ltd

Jubilant Life Sciences Ltd (Jubilant) is another such company that has destroyed shareholder’s wealth over the years. In last decade (2005-2014), it has retained earnings worth of INR 1,786 cr. whereas its market cap has increased by only INR 701 cr. Effectively, shareholder’s wealth of INR 1,085 cr. has been destroyed. It has failed miserably on the test of management highlighted by Warren Buffett that if the management should at least produce $1 in market value for $1 of earnings retained. Ideally, if any company is not able to invest money in its business profitably, then it should consider distributing its earnings to shareholders as dividends, rather than keeping it with itself and in turn investing in a suboptimal business.

Jubilant has been growing its sales but this growth has come at the cost of profitability. Sales have grown from INR 3,524 cr. in 2009 to INR 5,852 cr. in the latest four quarter. However, operating profitability (OPM) has declined from 20% in 2009 to 12% in latest 4 quarters. Despite a 66% increase in sales during these 6 years, the operating profit has remained stable at about INR 690 cr. The performance on net profitability is even worse. Net profitability (NPM) has declined from 16% in 2008 to negative in latest 4 quarters, indicating that during 2008-2014, despite increase in sales, net profit decreased from INR 400 cr. (2008) to loss of INR 2 cr. (latest 4 quarters).

In absence of good operating performance, Jubilant is relying on debt financing to fund its cash requirements. Over last decade, total debt of Jubilant Life Sciences has increased to almost eight times, from INR 372 cr. in 2005 to INR 2,905 cr. in 2014. The debt has reached almost 4,000 cr. in 2011. This huge debt will hurt the company in times of stress.

Therefore, looking at the past performance of Jubilant Life Sciences Ltd, it does not seem an attractive business to invest in. An investor can find many better opportunities in the current markets.

However, you should do your own analysis before you make any investment decision related to Jubilant Life Sciences or any other company.

Hope it helps.

Regards,

 

Analysis of Satluj Jal Vidyut Nigam (SJVN) Ltd 

Q: Hello can you please also give some light (fundamentally) on SJVN according to me the ratios that you mention are fully satisfied with this stock also. Thanks in advance.

 

Dr Vijay Malik’s Response

Thanks for writing to me!

 

Financial Analysis of Satluj Jal Vidyut Nigam Ltd (SJVN):

Satluj Jal Vidyut Nigam Ltd (SJVN) Financials

Topline of Satluj Jal Vidyut Nigam Ltd (SJVN) is almost stagnant since last many years. Though profitability margins are good, debt is low, however, I prefer investing in companies, which have grown their business at good growth rates.

However, as there is no single road to success, you should make your own call.

Regards,

P.S.

 

DISCLAIMER

  • The above discussion is only for educational purpose to help the readers improve their stock analysis skills. It is not a buy/sell/hold recommendation for the discussed stocks.
  • I am registered with SEBI as an Investment Adviser under SEBI (Investment Advisers) Regulations, 2013.
  • Currently, I do not own stocks of the companies mentioned above in my portfolio.

Related Posts:

Get FREE 4 e-books with 55 Companies Analysis

Subscribe And Get 4 Ebooks Free Portrait

Learn fundamental stock analysis by reading case studies in these e-books:​

Wonderla Holidays, Caplin Point Laboratories, MRF, TVS Srichakra, Divi’s Lab, Granules India, Finolex Cables, Finolex Industries, Chaman Lal Setia Exports, Ultramarine & Pigments, Balaji Amines, Bharat Rasayan, Maithan Alloys and many more.

Get email updates of our articles

Get email updates of our articles

  • Portfolio returns of 19.1% against Sensex returns of 11.5%.
  • We identified companies, which were later invested by Sanjay Bakshi, Mohnish Pabrai, PE funds, Mutual Funds
  • See details of stocks in our portfolio
  • Get updates of buy/sell transactions in our portfolio by email

“Peaceful Investing” is the result of my experience of more than a decade in stock markets. It aims to find such stocks, where after investing, an investor may sleep peacefully. If later on, the stock prices increase, then the investor is happy as she is now wealthier. If the stock prices decline, even then the investor is happy as she can now buy more quantity of the selected fundamentally good stocks.

Learn Balance Sheet Analysis Video Peaceful Investing Workshop On Demand
Play Video

Please share your comments here:

1. IMPORTANT: You MUST do a search on Google and on our website to find answer to your query before writing it here. It will save your time as well as our time.
2. To use images in the comments, upload them on any image sharing website and then use the link in the comments.
3. All comments are moderated. Your comment will be visible after we approve/reply to it.

Leave a Comment

Get FREE 4 e-books with 55 Companies Analysis

Subscribe And Get 4 Ebooks Free Portrait

Learn fundamental stock analysis by reading case studies in these e-books:​

Wonderla Holidays, Caplin Point Laboratories, MRF, TVS Srichakra, Divi’s Lab, Granules India, Finolex Cables, Finolex Industries, Chaman Lal Setia Exports, Ultramarine & Pigments, Balaji Amines, Bharat Rasayan, Maithan Alloys and many more.

Get email updates of our articles

Get email updates of our articles